Cita APA

Abad, M., Calabuig-Farinas, S., de Mena, M., Torres-Martinez, S., Gonzalez, C., Garcia, J., . . . Herrero, C. (2022). Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer.

Citación estilo Chicago

Abad, MN, S. Calabuig-Farinas, ML de Mena, S. Torres-Martinez, CG Gonzalez, JAG Garcia, VI Gonzalez-Cruz, y CC Herrero. Programmed Death-Ligand 1 (PD-L1) As Immunotherapy Biomarker in Breast Cancer. 2022.

Cita MLA

Abad, MN, et al. Programmed Death-Ligand 1 (PD-L1) As Immunotherapy Biomarker in Breast Cancer. 2022.